WEARING A MASK IS STILL REQUIRED IN PATIENT AREAS AT SUNNYBROOK. READ OUR VISITOR GUIDELINES »

Cancer trials
Hospital  >  Care Programs  >  Odette Cancer Program  >  Clinical trials

Trial details

Imaging biomarker for differentiating of radiation necrosis from tumour progression in brain metastasis treated with stereotactic radiosurgery

To find out more about this trial and your cancer treatment options, please speak with your doctor.

Trial short name: CEST Necrosis

Official title: Imaging biomarker for differentiating of radiation necrosis from tumour progression in brain metastasis treated with stereotactic radiosurgery

Principal Investigator: Dr. Hany Soliman

Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Other
Intervention: no intervention

Registration #:

Contact e-mail: cancerclinicaltrials@sunnybrook.ca